This invention relates to novel Quinazoline-2,4(1H,3H)-dione derivatives of Formula (I):
and their use as TRPC5 modulators, pharmaceutical compositions containing the same, and methods of using the same as agents for the treatment of TRPC5 receptor mediated disorders or conditions. R
1
, R
2
, R
3
and R
4
have meanings given in the description.
本发明涉及式(I)的新型
喹唑啉-2,4(1H,3H)-二酮衍
生物及其用作TRPC5调节剂,含有这些衍
生物的药物组合物以及将其用作TRPC5受体介导的疾病或病况的治疗剂的方法。其中,R1、R2、R3和R4的含义如描述中所示。